Clinical Trial Update: A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia [Phase 4]

View source ↗

Summary

A prospective/retrospective randomized controlled study evaluating interferon atomization for 2019-nCoV pneumonia (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• 2019-ncov Infection
• Pneumonia Due to 2019-ncov

Drugs mentioned

• Interferon atomization

Snippet

Sponsor: Tongji Hospital | Conditions: 2019-nCoV | Phase 4 | Status: UNKNOWN